High likelihood of success
The hybrid ablation procedure was developed at MUMC+ by Dr L. Pison (cardiologist) and Professor M. La Meir (cardiac surgeon), and performed for the first time in 2008. The unique collaboration between these two doctors has resulted in a procedure with much better outcomes than an ordinary catheter ablation. Success rates normally lie around 60%. The success rate of hybrid ablation – which is normally performed after multiple unsuccessful ablations or to treat long-term atrial fibrillation – is over 80%. Given the problematic nature of the condition, this extremely high success rate means that our hybrid ablation team are viewed as world leaders in the treatment of persistent atrial fibrillation. The current team members involved in this procedure can be found here.
The International Patient Office is there to help you
Our office can support and assist you when applying for treatment abroad with your health insurer. To facilitate your application, within 24 hours of your official diagnosis you will receive a quote for treatment and a medical file containing the diagnosis and proposed treatment plan. The International Patient Office works with case managers. These are academically trained healthcare professionals who serve as a single point of contact for all of your questions and requests. Your case manager will guide you through the treatment application process and be there to answer all of your questions before, during and after your treatment. The International Patient Office also has a hospitality service. If desired, your case manager can organise travel, accommodation, visa application and interpreting services tailored to your specific needs.